Topic

History of Diabetes and Insulin

Diabetes was recognized long before modern endocrinology could explain it. Physicians described thirst, wasting, sweet urine, and fatal decline, but for centuries treatment remained limited to regimen, diet, and uncertain theories of digestion, kidneys, and metabolism.

The discovery of insulin transformed diabetes from a frequently fatal condition into a chronic disease that could be managed, while also making patients dependent on laboratory production, supply chains, measurement, daily discipline, and access to continuing care.

Discovery

Insulin changed the prognosis of diabetes

Before insulin, strict diets could sometimes prolong life but often left patients weak, hungry, and still in danger. The Toronto work of Frederick Banting, Charles Best, J.J.R. Macleod, and James Collip changed what treatment could mean.

The insulin therapy timeline entry marks 1921 as a turning point, when pancreatic extracts lowered blood sugar in experimental animals and were soon refined for human use. Leonard Thompson's treatment in 1922 became one of the emblematic moments of twentieth-century therapeutic medicine.

Insulin also belongs to the history of medical infrastructure. It required animal pancreases, purification, standardization, commercial manufacture, refrigerated supply, clinical supervision, and later home monitoring. The therapy was life-saving, but never simple.

Chronic Care

Diabetes made modern patients managers of daily treatment

Diagnosis preceded effective treatment

Physicians could recognize diabetes through symptoms and urine long before they could alter its course. That gap between diagnosis and therapy defined much of pre-insulin diabetes history.

Insulin made survival depend on routine

The drug required timing, dose adjustment, diet, testing, and patient education. Diabetes care therefore became a collaboration between medical systems and daily life.

Access remained part of the history

Insulin's promise depended on cost, supply, medical supervision, and reliable distribution. The history of diabetes is therefore also a history of unequal access to life-sustaining therapy.